ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,845
0,37%
Bitcoin
57 378,38
-1,48%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Editas Medicine Inc (EDIT)

  7. Editas Medicine Inc (EDIT) Actualités

EDIT Editas Medicine Inc

5,54
0,33 (6,33%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Editas Medicine Inc EDIT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,33 6,33% 5,54 01:56:42
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,21 5,21 5,67 5,47 5,21
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
22/4/202422:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
06/3/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:58EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:06EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
21/2/202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
14/2/202414:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:00GLOBEEditas Medicine to Participate in Upcoming Investor..
08/1/202414:15GLOBEEditas Medicine Highlights 2024 Anticipated Milestones and..
03/1/202413:00GLOBEEditas Medicine to Present at the 42nd Annual J.P. Morgan..
13/12/202318:48DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202315:49DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202315:02EDGAR2Form 8-K - Current report
13/12/202315:00GLOBEEditas Medicine and Vertex Pharmaceuticals Enter into..
11/12/202322:23EDGAR2Form 8-K - Current report
11/12/202318:00GLOBEEditas Medicine Announces New EDIT-301 Safety and Efficacy..
07/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:10EDGAR2Form 8-K - Current report
16/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:06EDGAR2Form 8-K - Current report
03/11/202312:00GLOBEEditas Medicine Announces Third Quarter 2023 Results and..
02/11/202314:12GLOBEEditas Medicine to Present Clinical Data from the RUBY and..
27/10/202313:00GLOBEEditas Medicine Announces Third Quarter 2023 Results..
16/10/202314:00GLOBEEditas Medicine Granted FDA Regenerative Medicine Advanced..
10/10/202322:05EDGAR2Form 8-K - Current report
25/9/202322:30GLOBEEditas Medicine Reports Inducement Grants to New Chief..
25/9/202315:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
07/9/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:00GLOBEEditas Medicine Announces Upcoming Investor Events
28/8/202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
15/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:16EDGAR2Form 8-K - Current report
02/8/202313:00GLOBEEditas Medicine Announces Second Quarter 2023 Results and..
27/7/202315:00GLOBEEditas Medicine and Azzur Group Expand Partnership to..
26/7/202313:00GLOBEEditas Medicine Announces Second Quarter 2023 Results..
25/7/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/7/202314:00GLOBEEditas Medicine Reports Inducement Grant to New Chief..
24/7/202313:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
21/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
EDIT
Editas Medicine
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés